Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 248

    1.

    Counteraction of type 1 diabetic alterations by engineering skeletal muscle to produce insulin: insights from transgenic mice.

    Riu E, Mas A, Ferre T, Pujol A, Gros L, Otaegui P, Montoliu L, Bosch F.

    Diabetes. 2002 Mar;51(3):704-11.PMID: 11872670 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Reversal of type 1 diabetes by engineering a glucose sensor in skeletal muscle.

    Mas A, Montané J, Anguela XM, Muñoz S, Douar AM, Riu E, Otaegui P, Bosch F.

    Diabetes. 2006 Jun;55(6):1546-53.PMID: 16731816 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Expression of glucokinase in skeletal muscle: a new approach to counteract diabetic hyperglycemia.

    Otaegui PJ, Ferre T, Pujol A, Riu E, Jimenez R, Bosch F.

    Hum Gene Ther. 2000 Jul 20;11(11):1543-52.PMID: 10945768 [PubMed - indexed for MEDLINE]Related articles

    4.

    Glucose-regulated glucose uptake by transplanted muscle cells expressing glucokinase counteracts diabetic hyperglycemia.

    Otaegui PJ, Ontiveros M, Ferre T, Riu E, Jiménez R, Bosch F.

    Hum Gene Ther. 2002 Dec 10;13(18):2125-33.PMID: 12542844 [PubMed - indexed for MEDLINE]Related articles

    5.

    Regulated expression of human insulin in the liver of transgenic mice corrects diabetic alterations.

    Valera A, Fillat C, Costa C, Sabater J, Visa J, Pujol A, Bosch F.

    FASEB J. 1994 Apr 1;8(6):440-7.PMID: 8168695 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Glucose transporter-2 (GLUT2) promoter mediated transgenic insulin production reduces hyperglycemia in diabetic mice.

    Burkhardt BR, Parker MJ, Zhang YC, Song S, Wasserfall CH, Atkinson MA.

    FEBS Lett. 2005 Oct 24;579(25):5759-64. Epub 2005 Oct 5.PMID: 16223491 [PubMed - indexed for MEDLINE]Related articles

    8.

    Insulin expression in livers of diabetic mice mediated by hydrodynamics-based administration.

    He CX, Shi D, Wu WJ, Ding YF, Feng DM, Lu B, Chen HM, Yao JH, Shen Q, Lu DR, Xue JL.

    World J Gastroenterol. 2004 Feb 15;10(4):567-72.PMID: 14966918 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Enhanced diabetogenic effect of streptozotocin in mice overexpressing UCP-3 in skeletal muscle.

    Wang S, Cawthorne MA, Clapham JC.

    Ann N Y Acad Sci. 2002 Jun;967:112-9.PMID: 12079841 [PubMed - indexed for MEDLINE]Related articles

    10.

    Regulated hepatic insulin gene therapy of STZ-diabetic rats.

    Thulé PM, Liu JM.

    Gene Ther. 2000 Oct;7(20):1744-52.PMID: 11083496 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Improvement of insulin action in diabetic transgenic mice selectively overexpressing GLUT4 in skeletal muscle.

    Leturque A, Loizeau M, Vaulont S, Salminen M, Girard J.

    Diabetes. 1996 Jan;45(1):23-7.PMID: 8522055 [PubMed - indexed for MEDLINE]Related articles

    12.

    Release of transgenic human insulin from gastric g cells: a novel approach for the amelioration of diabetes.

    Lu YC, Sternini C, Rozengurt E, Zhukova E.

    Endocrinology. 2005 Jun;146(6):2610-9. Epub 2005 Feb 24.PMID: 15731364 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Gene therapy of streptozotocin-induced diabetes by intramuscular delivery of modified preproinsulin genes.

    Croze F, Prud'homme GJ.

    J Gene Med. 2003 May;5(5):425-37.PMID: 12731091 [PubMed - indexed for MEDLINE]Related articles

    14.

    Safety and efficacy of adeno-associated viral vector-mediated insulin gene transfer via portal vein to the livers of streptozotocin-induced diabetic Sprague-Dawley rats.

    Park YM, Woo S, Lee GT, Ko JY, Lee Y, Zhao ZS, Kim HJ, Ahn CW, Cha BS, Kim KS, Park CW, Lee HC.

    J Gene Med. 2005 May;7(5):621-9.PMID: 15651056 [PubMed - indexed for MEDLINE]Related articles

    15.

    Genetically engineered K cells provide sufficient insulin to correct hyperglycemia in a nude murine model.

    Zhang Y, Yao L, Shen K, Xu M, Zhou P, Yang W, Liu X, Qin X.

    Acta Biochim Biophys Sin (Shanghai). 2008 Feb;40(2):149-57.PMID: 18235977 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Hepatic insulin expression improves glycemic control in type 1 diabetic rats.

    Dong H, Morral N, McEvoy R, Meseck M, Thung SN, Woo SL.

    Diabetes Res Clin Pract. 2001 Jun;52(3):153-63.PMID: 11323084 [PubMed - indexed for MEDLINE]Related articles

    17.

    Prevention of obesity and insulin resistance by glucokinase expression in skeletal muscle of transgenic mice.

    Otaegui PJ, Ferre T, Riu E, Bosch F.

    FASEB J. 2003 Nov;17(14):2097-9. Epub 2003 Sep 18.PMID: 14500548 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.
    19.

    Correction of diabetic alterations by glucokinase.

    Ferre T, Pujol A, Riu E, Bosch F, Valera A.

    Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7225-30.PMID: 8692973 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Activation of the hexosamine signaling pathway in adipose tissue results in decreased serum adiponectin and skeletal muscle insulin resistance.

    Hazel M, Cooksey RC, Jones D, Parker G, Neidigh JL, Witherbee B, Gulve EA, McClain DA.

    Endocrinology. 2004 May;145(5):2118-28. Epub 2003 Dec 18.PMID: 14684615 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data